Tenet Healthcare (THC) AI Stock Analysis

• Market Cap: $16.48B
• Dividend Yield: N/A
• Average Volume (3M): 1.65M
• Price to Earnings (P/E): 11.4
• Beta (1Y): 1.16
• Revenue Growth: -1.79%
• EPS Growth: -41.85%
• Country: US
• Employees: 98,000
• Sector: Healthcare
• Sector Strength: 47
• Industry: Medical - Care Facilities
• EPS (TTM): 4.36
• Shares Outstanding: 92,885,000
• 10 Day Avg. Volume: 1,778,634
• 30 Day Avg. Volume: 1,647,128
• PEG Ratio: -0.16
• Price to Book (P/B): 4.57
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 16.25
• Enterprise Value/Market Cap: 1.18
• Enterprise Value/Revenue: 0.23
• Enterprise Value/Gross Profit: 2.00
• Enterprise Value/Ebitda: 1.16
• 1Y Price Target: $187.50
• Price Target Upside: 8.87% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 16

• Rating: 71 Outperform
• Price Target: $190.00 ▲(10.32%Upside)

Tenet Healthcare's strong operational efficiency and profitability metrics are the primary drivers of its stock score. The positive earnings momentum and strategic corporate events further bolster the score, despite valuation concerns and policy uncertainties posing potential risks.

Positive Factors

Partnerships

USPI’s ability to get strong pricing and low costs on supplies, coupled with its national support infrastructure make it a compelling partner for physicians who want to be part of an ASC.

Strategic Goals

The company remains steadfast in achieving its strategic goals of growth, capital deployment, cost control and expanding the ASC business despite policy and macro uncertainties.

Negative Factors

Medicaid Cuts

The cuts to Medicaid appear to be tracking in line with a softer landing thesis with perhaps further moderation to come when the Senate gets done with the bill.

Policy Uncertainty

Despite anticipated growth in supplies and other OpEx expenses, there is an acknowledgment of the possibility of recession fears altering consumer consumption dynamics.

Tenet Healthcare Business Overview & Revenue Model

Company Description

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.

How the Company Makes Money

Tenet Healthcare generates revenue primarily through patient services provided at its hospitals, outpatient centers, and urgent care facilities. The company earns money from patient admissions, surgeries, diagnostic services, and other medical procedures. A significant portion of its revenue comes from agreements with private insurance companies, government health programs like Medicare and Medicaid, and direct payments from patients. Additionally, Tenet's subsidiary, United Surgical Partners International, contributes to its earnings by operating surgical facilities in partnership with physicians. Conifer Health Solutions, another key subsidiary, provides revenue cycle management and value-based care services, further enhancing the company's financial performance. Strategic partnerships and acquisitions also play a crucial role in expanding Tenet's service offerings and market presence, driving revenue growth.

Tenet Healthcare Financial Statement Overview

Summary

Tenet Healthcare exhibits strong operational efficiency and cash flow management, with impressive profitability metrics and a significantly improved debt position. However, the company must continue focusing on revenue growth and expanding its equity base to mitigate risks associated with a relatively high liability level.

Income Statement

Tenet Healthcare shows strong profitability with a consistent gross profit margin of around 47.3% TTM. The net profit margin has seen fluctuations but stands at a healthy 8.1% TTM. Revenue growth is stable with a slight decrease in the latest TTM compared to the previous year. The company maintains robust EBIT and EBITDA margins at 17.2% and 18.3% respectively, indicating efficient operations. However, the recent decline in net income and revenue growth could pose concerns if not addressed.

Balance Sheet

The company's balance sheet reveals a solid equity ratio of 14.3% TTM, showing a reasonable level of financial stability. The debt-to-equity ratio has improved significantly, dropping to 0.02, reflecting effective debt management. Return on equity is impressive at 40%, indicating strong profitability relative to shareholder equity. However, the overall equity base remains relatively small compared to total liabilities, which could pose risks during financial downturns.

Cash Flow

Cash flow analysis indicates a strong free cash flow growth rate of 27.4% TTM, highlighting improved cash generation capabilities. The operating cash flow to net income ratio is robust at 1.36, demonstrating efficient cash flow management. The free cash flow to net income ratio is also solid at 0.85, suggesting effective use of cash. Despite this, the company must maintain its focus on sustaining cash flow growth amid fluctuating net income levels.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	20.52B	20.66B	20.55B	19.17B	19.48B	17.64B
Gross Profit	9.71B	11.86B	16.96B	15.90B	16.16B	14.66B
EBITDA	4.44B	6.89B	3.39B	3.33B	3.42B	2.43B
Net Income	1.46B	3.20B	611.00M	1.00B	1.48B	768.00M
Balance Sheet
Total Assets	29.24B	28.94B	28.31B	27.16B	27.58B	27.11B
Cash, Cash Equivalents and Short-Term Investments	3.00B	3.02B	1.23B	858.00M	2.36B	2.45B
Total Debt	13.17B	13.17B	16.21B	15.08B	15.65B	15.72B
Total Liabilities	20.58B	20.39B	22.80B	22.55B	23.32B	24.22B
Stockholders Equity	4.18B	4.17B	1.61B	1.14B	1.03B	28.00M
Cash Flow
Free Cash Flow	1.42B	1.12B	1.62B	321.00M	910.00M	2.87B
Operating Cash Flow	2.28B	2.05B	2.37B	1.08B	1.57B	3.41B
Investing Cash Flow	-117.00M	3.43B	-969.00M	-808.00M	-714.00M	-1.61B
Financing Cash Flow	-1.64B	-3.69B	-1.03B	-1.78B	-936.00M	385.00M

Tenet Healthcare Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 172.22
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For THC, the sentiment is Positive. The current price of 172.22 is above the 20-day moving average (MA) of 168.80, above the 50-day MA of 158.77, and above the 200-day MA of 145.37, indicating a bullish trend. The MACD of 4.11 indicates Negative momentum. The RSI at 57.90 is Neutral, neither overbought nor oversold. The STOCH value of 78.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for THC.

Tenet Healthcare Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
UHS	77 Outperform	$12.17B	10.61	18.35%	0.42%	9.73%	51.87%
FMS	77 Outperform	$16.90B	25.02	4.36%	2.73%	-0.91%	27.17%
HCA	76 Outperform	$93.71B	17.31	-230.22%	0.74%	7.30%	11.60%
EHC	75 Outperform	$12.14B	24.86	25.33%	0.56%	11.21%	30.38%
THC	71 Outperform	$16.48B	11.39	38.12%	―	-1.79%	-41.85%
DVA	66 Neutral	$11.08B	14.11	260.92%	―	5.11%	14.28%
Sector *	51 Neutral	$7.55B	0.30	-61.90%	2.27%	17.11%	1.58%

Tenet Healthcare Corporate Events

Tenet Healthcare Appoints Lisa Y. Foo as COO

On May 30, 2025, Tenet Healthcare Corporation announced the promotion of Lisa Y. Foo to the newly created position of Chief Operating Officer, effective immediately. This strategic move is expected to enhance the company’s operational leadership and potentially strengthen its market position.

The most recent analyst rating on (THC) stock is a Buy with a $136.00 price target. To see the full list of analyst forecasts on Tenet Healthcare stock, see the THC Stock Forecast page.

Tenet Healthcare Holds Annual Shareholder Meeting

On May 22, 2025, Tenet Healthcare Corporation held its Annual Meeting of Shareholders, where several key decisions were made. Shareholders elected directors to the board, approved executive compensation, and ratified Deloitte & Touche LLP as the independent accountants for 2025. However, a proposal for a report on improving maternal health outcomes was not approved, indicating a lack of consensus on this issue among shareholders.

The most recent analyst rating on (THC) stock is a Buy with a $184.00 price target. To see the full list of analyst forecasts on Tenet Healthcare stock, see the THC Stock Forecast page.